EP3071219
Aðferðir við að meðhöndla mótefnaháða höfnun hjá líffæraígræðslu sjúklingum með C1-esterasa hemil
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
21.11.2014EP published:
14.11.2018EP application number:
14809567.2
EP translation filed:
22.1.2019Grant published:
15.2.2019EPO information:
European Patent Register
Max expiry date:
20.11.2034Expiry date:
20.11.2025
Title:
METHODS OF TREATING ANTIBODY-MEDIATED REJECTION IN ORGAN TRANSPLANT PATIENTS WITH C1-ESTERASE INHIBITOR
Timeline
Today
21.11.2014EP application
14.11.2018EP Publication
22.1.2019Translation submitted
15.2.2019Registration published
20.11.2025Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
BROOM, ColinAddress:
Devon, PA, US
Name:
UKNIS, Marc, E.Address:
Chadds Ford, PA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361907550 PDate:
22.11.2013Country:
US
Number:
201462029086 PDate:
25.7.2014Country:
US
Classification
Categories:
A61K 38/55, A61K 35/16, A61K 39/395, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 14.12.2018
Expires: 20.11.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 6
Paid: 21.10.2019
Expires: 20.11.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 7
Paid: 20.10.2020
Expires: 20.11.2021
Payer: Patice ehf.
Number: 8
Paid: 20.10.2021
Expires: 20.11.2022
Payer: Patice ehf.
Number: 9
Paid: 20.10.2022
Expires: 20.11.2023
Payer: Patice ehf.
Number: 9
Paid: 20.10.2022
Expires: 20.11.2023
Payer: Patice ehf.
Number: 10
Paid: 6.11.2023
Expires: 20.11.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 25.10.2024
Expires: 20.11.2025
Payer: Árnason Faktor ehf.